Mucosal escherichia coli bactericidal activity and immune mediators are associated with HIV-1 seroconversion in women participating in the HPTN 035 trial

Journal of Infectious Diseases

Volumn 206, Issue 12, 2012, Pages 1931-1935

  Dezzutti, Charlene S ^a   Richardson, Barbra A ^b,c   Marrazzo, Jeanne M ^b   Tugetman, Jessica ^d   Ramjee, Gita ^e   Taha, Taha ^f   Chirenje, Zvavahera M ^g   Abdool Karim, Salim S ^h   Hillier, Sharon L ^a   Herold, Betsy C ^d  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c Fred Hutchinson Cancer Research Center   (United States)

^d ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^e SOUTH AFRICAN MEDICAL RESEARCH COUNCIL   (South Africa)

^f JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^g UNIVERSITY OF ZIMBABWE   (Zimbabwe)

^h UNIVERSITY OF KWAZULU NATAL   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; MACROPHAGE INFLAMMATORY PROTEIN;

ARTICLE; BACTERICIDAL ACTIVITY; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; ESCHERICHIA COLI; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; INFECTION RISK; MAJOR CLINICAL STUDY; MUCOSAL IMMUNITY; PRIORITY JOURNAL; SEROCONVERSION; VAGINA DISCHARGE; ZIMBABWE;

BIOLOGICAL MARKERS; BODILY SECRETIONS; ESCHERICHIA COLI; FEMALE; HIV INFECTIONS; HIV SEROPOSITIVITY; HIV-1; HUMANS; IMMUNITY, MUCOSAL; MICROBIAL VIABILITY; VAGINA;

EID: 84870208216     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jis555     Document Type: Article

References (15)

1. WHO/UNAIDS/UNICEF. Global HIV/AIDS response. Geneva: UNAIDS, 2011:229.
2. Abdool Karim SS, Richardson BA, Ramjee G, et al. Safety and effectiveness of BufferGel and 0.5% PRO2000 gel for the prevention of HIV infection in women. AIDS 2011; 25:957-66.
3. McCormack S, Ramjee G, Kamali A, et al. PRO2000 vaginal gel for prevention of HIV-1 infection (Microbicides Development Programme 301): A phase 3, randomised, double-blind, parallel-group trial. Lancet 2010; 376:1329-37.
4. Skoler-Karpoff S, Ramjee G, Ahmed K, et al. Efficacy of Carraguard for prevention of HIV infection in women in South Africa: A randomised, double-blind, placebo-controlled trial. Lancet 2008; 372: 1977-87.
5. Van Damme L, Govinden R, Mirembe FM, et al. Lack of effectiveness of cellulose sulfate gel for the prevention of vaginal HIV transmission. N Engl J Med 2008; 359:463-72.
6. Patel S, Hazrati E, Cheshenko N, et al. Seminal plasma reduces the effectiveness of topical polyanionic microbicides. J Infect Dis 2007; 196:1394-402. (Pubitemid 351412013)
7. Valore EV, Park CH, Igreti SL, Ganz T. Antimicrobial components of vaginal fluid. Am J Obstet Gynecol 2002; 187:561-8.
8. Dezzutti CS, Hendrix CW, Marrazzo JM, et al. Performance of swabs, lavage, and diluents to quantify biomarkers of female genital tract soluble mucosal mediators. PLoS One 2011; 6:e23136.
9. Hickey DK, Patel MV, Fahey JV, Wira CR. Innate and adaptive immunity at mucosal surfaces of the female reproductive tract: Stratification and integration of immune protection against the transmission of sexually transmitted infections. J Reprod Immunol 2011; 88:185-94.
10. Roberts L, Passmore J-A, Williamson C, et al. Genital tract inflammation in women participating in the CARPISA TFV microbicide trail who became infected with HIV: A mechanism for breakthrough infection [abstract 991]? In: Conference on Retroviruses and Opportunistic Infections (Boston, MA). Alexandria, VA: CROI, 2011:474.
11. Valore EV, Wiley DJ, Ganz T. Reversible deficiency of antimicrobial polypeptides in bacterial vaginosis. Infect Immun 2006; 74:5693-702. (Pubitemid 44484553)
12. Peltekova VD, Wintle RF, Rubin LA, et al. Functional variants of OCTN cation transporter genes are associated with Crohn disease. Nat Genet 2004; 36:471-5. (Pubitemid 38620030)
13. Cario E, Podolsky DK. Differential alteration in intestinal epithelial cell expression of toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease. Infect Immun 2000; 68:7010-7. (Pubitemid 32463415)
14. Strober W, Fuss I, Mannon P. The fundamental basis of inflammatory bowel disease. J Clin Invest 2007; 117:514-21. (Pubitemid 46348505)
15. Genc MR, Vardhana S, Delaney ML, et al. Relationship between a toll-like receptor-4 gene polymorphism, bacterial vaginosis-related flora and vaginal cytokine responses in pregnant women. Eur J Obstet Gynecol Reprod Biol 2004; 116:152-6. (Pubitemid 39195125)